Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2015 | 03-2015 | 12-2014 | |
| Operating Expenses | 24,879 | 0 | 0 |
| Operating Income | -24,879 | N/A | N/A |
| Pre-tax Income | -24,879 | 0 | 0 |
| Income Tax | 74 | N/A | N/A |
| Net Income Continuous | -24,953 | N/A | N/A |
| Net Income | $-24,953 | $N/A | $N/A |
| EPS Basic Total Ops | -2.48 | N/A | N/A |
| EPS Basic Continuous Ops | -2.49 | N/A | N/A |
| EPS Diluted Total Ops | -2.48 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.49 | N/A | N/A |
| EBITDA(a) | $-24,878 | $N/A | $N/A |